Insights

Niche Focus Orphazyme specializes in rare neurodegenerative and orphan diseases, presenting opportunities to develop targeted therapies and personalized medicine solutions tailored to these specialized markets.

Late-Stage Pipeline With a focus on advanced drug candidates and ongoing patent assets, there is potential to engage in collaborations, licensing, or supply agreements as the company advances towards commercialization.

Recent Asset Sales The sale of key assets and strategic partnerships indicates possible avenues for joint ventures, technology licensing, or supply chain integrations in the rare disease treatment space.

Expanding US Presence The company's growing operations in the United States signal opportunities to offer downstream products, clinical support services, or distribution partnerships within the American healthcare market.

Funding & Growth Opportunities Despite modest revenue, the substantial funding received provides a pathway for expanding collaborations in biopharmaceutical research, diagnostics, or ancillary services supporting clinical development.

Orphazyme A/S Tech Stack

Orphazyme A/S uses 8 technology products and services including Google Cloud, IBM, Underscore.js, and more. Explore Orphazyme A/S's tech stack below.

  • Google Cloud
    Infrastructure As A Service
  • IBM
    IT
  • Underscore.js
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Adobe Fonts
    Web Fonts
  • Twitter
    Widgets

Media & News

Orphazyme A/S's Email Address Formats

Orphazyme A/S uses at least 1 format(s):
Orphazyme A/S Email FormatsExamplePercentage
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

Minus sign iconPlus sign icon
Orphazyme A/S's main headquarters is located at DK. The company has employees across 2 continents, including EuropeNorth America.

What is Orphazyme A/S's phone number?

Minus sign iconPlus sign icon
You can contact Orphazyme A/S's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orphazyme A/S's stock symbol?

Minus sign iconPlus sign icon
Orphazyme A/S is a publicly traded company; the company's stock symbol is ORPHY.

What is Orphazyme A/S's official website and social media links?

Minus sign iconPlus sign icon
Orphazyme A/S's official website is orphazyme.com and has social profiles on LinkedIn.

What is Orphazyme A/S's SIC code NAICS code?

Minus sign iconPlus sign icon
Orphazyme A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orphazyme A/S have currently?

Minus sign iconPlus sign icon
As of August 2025, Orphazyme A/S has approximately 108 employees across 2 continents, including EuropeNorth America. Key team members include Executive Director, Payer Engagement: T. D.Statistics Specialist: T. H.: C. B.. Explore Orphazyme A/S's employee directory with LeadIQ.

What industry does Orphazyme A/S belong to?

Minus sign iconPlus sign icon
Orphazyme A/S operates in the Biotechnology Research industry.

What technology does Orphazyme A/S use?

Minus sign iconPlus sign icon
Orphazyme A/S's tech stack includes Google CloudIBMUnderscore.jsjQuery UIjQuery MigrateYoast SEOAdobe FontsTwitter.

What is Orphazyme A/S's email format?

Minus sign iconPlus sign icon
Orphazyme A/S's email format typically follows the pattern of First.Last@orphazyme.com. Find more Orphazyme A/S email formats with LeadIQ.

How much funding has Orphazyme A/S raised to date?

Minus sign iconPlus sign icon
As of August 2025, Orphazyme A/S has raised $109M in funding. The last funding round occurred on Feb 07, 2020 for $109M.

When was Orphazyme A/S founded?

Minus sign iconPlus sign icon
Orphazyme A/S was founded in 2009.
Orphazyme A/S

Orphazyme A/S

Biotechnology ResearchDenmark51-200 Employees

Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases.

Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago.

See our community guidelines: bit.ly/3uapRYr

Section iconCompany Overview

Headquarters
DK
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ORPHY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

  • $1M

    Orphazyme A/S's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

  • $1M

    Orphazyme A/S's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.